Global Intravenous Iron Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Intravenous Iron Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Intravenous Iron Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Ferric Gluconate
  • 1.2.3 Ferric Carboxymaltose
  • 1.2.4 Iron Sucrose
  • 1.2.5 Iron Dextran
• 1.3 Market by Application
  • 1.3.1 Global Intravenous Iron Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Nephrology
  • 1.3.3 Gynecology & Obstetrics
  • 1.3.4 Gastroenterology
  • 1.3.5 Oncology
  • 1.3.6 Cardiology
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Intravenous Iron Drugs Sales Estimates and Forecasts 2017-2028
• 2.2 Global Intravenous Iron Drugs Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Intravenous Iron Drugs Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Intravenous Iron Drugs Sales by Region
  • 2.4.1 Global Intravenous Iron Drugs Sales by Region (2017-2022)
  • 2.4.2 Global Sales Intravenous Iron Drugs by Region (2023-2028)
• 2.5 Global Intravenous Iron Drugs Revenue by Region
  • 2.5.1 Global Intravenous Iron Drugs Revenue by Region (2017-2022)
  • 2.5.2 Global Intravenous Iron Drugs Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Intravenous Iron Drugs Sales by Manufacturers
  • 3.1.1 Global Top Intravenous Iron Drugs Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Intravenous Iron Drugs Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous Iron Drugs in 2021
• 3.2 Global Intravenous Iron Drugs Revenue by Manufacturers
  • 3.2.1 Global Intravenous Iron Drugs Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Intravenous Iron Drugs Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Intravenous Iron Drugs Revenue in 2021
• 3.3 Global Intravenous Iron Drugs Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Intravenous Iron Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Intravenous Iron Drugs Sales by Type
  • 4.1.1 Global Intravenous Iron Drugs Historical Sales by Type (2017-2022)
  • 4.1.2 Global Intravenous Iron Drugs Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Intravenous Iron Drugs Sales Market Share by Type (2017-2028)
• 4.2 Global Intravenous Iron Drugs Revenue by Type
  • 4.2.1 Global Intravenous Iron Drugs Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Intravenous Iron Drugs Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Intravenous Iron Drugs Revenue Market Share by Type (2017-2028)
• 4.3 Global Intravenous Iron Drugs Price by Type
  • 4.3.1 Global Intravenous Iron Drugs Price by Type (2017-2022)
  • 4.3.2 Global Intravenous Iron Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Intravenous Iron Drugs Sales by Application
  • 5.1.1 Global Intravenous Iron Drugs Historical Sales by Application (2017-2022)
  • 5.1.2 Global Intravenous Iron Drugs Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Intravenous Iron Drugs Sales Market Share by Application (2017-2028)
• 5.2 Global Intravenous Iron Drugs Revenue by Application
  • 5.2.1 Global Intravenous Iron Drugs Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Intravenous Iron Drugs Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Intravenous Iron Drugs Revenue Market Share by Application (2017-2028)
• 5.3 Global Intravenous Iron Drugs Price by Application
  • 5.3.1 Global Intravenous Iron Drugs Price by Application (2017-2022)
  • 5.3.2 Global Intravenous Iron Drugs Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Intravenous Iron Drugs Market Size by Type
  • 6.1.1 North America Intravenous Iron Drugs Sales by Type (2017-2028)
  • 6.1.2 North America Intravenous Iron Drugs Revenue by Type (2017-2028)
• 6.2 North America Intravenous Iron Drugs Market Size by Application
  • 6.2.1 North America Intravenous Iron Drugs Sales by Application (2017-2028)
  • 6.2.2 North America Intravenous Iron Drugs Revenue by Application (2017-2028)
• 6.3 North America Intravenous Iron Drugs Market Size by Country
  • 6.3.1 North America Intravenous Iron Drugs Sales by Country (2017-2028)
  • 6.3.2 North America Intravenous Iron Drugs Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Intravenous Iron Drugs Market Size by Type
  • 7.1.1 Europe Intravenous Iron Drugs Sales by Type (2017-2028)
  • 7.1.2 Europe Intravenous Iron Drugs Revenue by Type (2017-2028)
• 7.2 Europe Intravenous Iron Drugs Market Size by Application
  • 7.2.1 Europe Intravenous Iron Drugs Sales by Application (2017-2028)
  • 7.2.2 Europe Intravenous Iron Drugs Revenue by Application (2017-2028)
• 7.3 Europe Intravenous Iron Drugs Market Size by Country
  • 7.3.1 Europe Intravenous Iron Drugs Sales by Country (2017-2028)
  • 7.3.2 Europe Intravenous Iron Drugs Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Intravenous Iron Drugs Market Size by Type
  • 8.1.1 Asia Pacific Intravenous Iron Drugs Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Intravenous Iron Drugs Revenue by Type (2017-2028)
• 8.2 Asia Pacific Intravenous Iron Drugs Market Size by Application
  • 8.2.1 Asia Pacific Intravenous Iron Drugs Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Intravenous Iron Drugs Revenue by Application (2017-2028)
• 8.3 Asia Pacific Intravenous Iron Drugs Market Size by Region
  • 8.3.1 Asia Pacific Intravenous Iron Drugs Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Intravenous Iron Drugs Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Intravenous Iron Drugs Market Size by Type
  • 9.1.1 Latin America Intravenous Iron Drugs Sales by Type (2017-2028)
  • 9.1.2 Latin America Intravenous Iron Drugs Revenue by Type (2017-2028)
• 9.2 Latin America Intravenous Iron Drugs Market Size by Application
  • 9.2.1 Latin America Intravenous Iron Drugs Sales by Application (2017-2028)
  • 9.2.2 Latin America Intravenous Iron Drugs Revenue by Application (2017-2028)
• 9.3 Latin America Intravenous Iron Drugs Market Size by Country
  • 9.3.1 Latin America Intravenous Iron Drugs Sales by Country (2017-2028)
  • 9.3.2 Latin America Intravenous Iron Drugs Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Intravenous Iron Drugs Market Size by Type
  • 10.1.1 Middle East and Africa Intravenous Iron Drugs Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Intravenous Iron Drugs Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Intravenous Iron Drugs Market Size by Application
  • 10.2.1 Middle East and Africa Intravenous Iron Drugs Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Intravenous Iron Drugs Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Intravenous Iron Drugs Market Size by Country
  • 10.3.1 Middle East and Africa Intravenous Iron Drugs Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Intravenous Iron Drugs Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Allergan
  • 11.1.1 Allergan Corporation Information
  • 11.1.2 Allergan Overview
  • 11.1.3 Allergan Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Allergan Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Allergan Recent Developments
• 11.2 AMAG Pharmaceuticals
  • 11.2.1 AMAG Pharmaceuticals Corporation Information
  • 11.2.2 AMAG Pharmaceuticals Overview
  • 11.2.3 AMAG Pharmaceuticals Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 AMAG Pharmaceuticals Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 AMAG Pharmaceuticals Recent Developments
• 11.3 Daiichi Sankyo
  • 11.3.1 Daiichi Sankyo Corporation Information
  • 11.3.2 Daiichi Sankyo Overview
  • 11.3.3 Daiichi Sankyo Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Daiichi Sankyo Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Daiichi Sankyo Recent Developments
• 11.4 Galenica
  • 11.4.1 Galenica Corporation Information
  • 11.4.2 Galenica Overview
  • 11.4.3 Galenica Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Galenica Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Galenica Recent Developments
• 11.5 Pharmacosmos
  • 11.5.1 Pharmacosmos Corporation Information
  • 11.5.2 Pharmacosmos Overview
  • 11.5.3 Pharmacosmos Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Pharmacosmos Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Pharmacosmos Recent Developments
• 11.6 Nippon Shinyaku
  • 11.6.1 Nippon Shinyaku Corporation Information
  • 11.6.2 Nippon Shinyaku Overview
  • 11.6.3 Nippon Shinyaku Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Nippon Shinyaku Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Nippon Shinyaku Recent Developments
• 11.7 NOXXON Pharma
  • 11.7.1 NOXXON Pharma Corporation Information
  • 11.7.2 NOXXON Pharma Overview
  • 11.7.3 NOXXON Pharma Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 NOXXON Pharma Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 NOXXON Pharma Recent Developments
• 11.8 Rockwell Medical
  • 11.8.1 Rockwell Medical Corporation Information
  • 11.8.2 Rockwell Medical Overview
  • 11.8.3 Rockwell Medical Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Rockwell Medical Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Rockwell Medical Recent Developments
• 11.9 Sanofi
  • 11.9.1 Sanofi Corporation Information
  • 11.9.2 Sanofi Overview
  • 11.9.3 Sanofi Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Sanofi Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Sanofi Recent Developments
• 11.10 Wanbang Biopharmaceutical
  • 11.10.1 Wanbang Biopharmaceutical Corporation Information
  • 11.10.2 Wanbang Biopharmaceutical Overview
  • 11.10.3 Wanbang Biopharmaceutical Intravenous Iron Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Wanbang Biopharmaceutical Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Wanbang Biopharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Intravenous Iron Drugs Industry Chain Analysis
• 12.2 Intravenous Iron Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Intravenous Iron Drugs Production Mode & Process
• 12.4 Intravenous Iron Drugs Sales and Marketing
  • 12.4.1 Intravenous Iron Drugs Sales Channels
  • 12.4.2 Intravenous Iron Drugs Distributors
• 12.5 Intravenous Iron Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Intravenous Iron Drugs Industry Trends
• 13.2 Intravenous Iron Drugs Market Drivers
• 13.3 Intravenous Iron Drugs Market Challenges
• 13.4 Intravenous Iron Drugs Market Restraints

14 Key Findings in The Global Intravenous Iron Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Intravenous Iron Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Ferric Gluconate
• Table 3. Major Manufacturers of Ferric Carboxymaltose
• Table 4. Major Manufacturers of Iron Sucrose
• Table 5. Major Manufacturers of Iron Dextran
• Table 6. Global Intravenous Iron Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Intravenous Iron Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Intravenous Iron Drugs Sales by Region (2017-2022) & (K Units)
• Table 9. Global Intravenous Iron Drugs Sales Market Share by Region (2017-2022)
• Table 10. Global Intravenous Iron Drugs Sales by Region (2023-2028) & (K Units)
• Table 11. Global Intravenous Iron Drugs Sales Market Share by Region (2023-2028)
• Table 12. Global Intravenous Iron Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 13. Global Intravenous Iron Drugs Revenue Market Share by Region (2017-2022)
• Table 14. Global Intravenous Iron Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 15. Global Intravenous Iron Drugs Revenue Market Share by Region (2023-2028)
• Table 16. Global Intravenous Iron Drugs Sales by Manufacturers (2017-2022) & (K Units)
• Table 17. Global Intravenous Iron Drugs Sales Share by Manufacturers (2017-2022)
• Table 18. Global Intravenous Iron Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 19. Global Intravenous Iron Drugs Revenue Share by Manufacturers (2017-2022)
• Table 20. Intravenous Iron Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
• Table 21. Global Intravenous Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Intravenous Iron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Iron Drugs as of 2021)
• Table 23. Intravenous Iron Drugs Manufacturing Base Distribution and Headquarters
• Table 24. Manufacturers Intravenous Iron Drugs Product Offered
• Table 25. Date of Manufacturers Enter into Intravenous Iron Drugs Market
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Intravenous Iron Drugs Sales by Type (2017-2022) & (K Units)
• Table 28. Global Intravenous Iron Drugs Sales by Type (2023-2028) & (K Units)
• Table 29. Global Intravenous Iron Drugs Sales Share by Type (2017-2022)
• Table 30. Global Intravenous Iron Drugs Sales Share by Type (2023-2028)
• Table 31. Global Intravenous Iron Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 32. Global Intravenous Iron Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 33. Global Intravenous Iron Drugs Revenue Share by Type (2017-2022)
• Table 34. Global Intravenous Iron Drugs Revenue Share by Type (2023-2028)
• Table 35. Intravenous Iron Drugs Price by Type (2017-2022) & (USD/Unit)
• Table 36. Global Intravenous Iron Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
• Table 37. Global Intravenous Iron Drugs Sales by Application (2017-2022) & (K Units)
• Table 38. Global Intravenous Iron Drugs Sales by Application (2023-2028) & (K Units)
• Table 39. Global Intravenous Iron Drugs Sales Share by Application (2017-2022)
• Table 40. Global Intravenous Iron Drugs Sales Share by Application (2023-2028)
• Table 41. Global Intravenous Iron Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 42. Global Intravenous Iron Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 43. Global Intravenous Iron Drugs Revenue Share by Application (2017-2022)
• Table 44. Global Intravenous Iron Drugs Revenue Share by Application (2023-2028)
• Table 45. Intravenous Iron Drugs Price by Application (2017-2022) & (USD/Unit)
• Table 46. Global Intravenous Iron Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
• Table 47. North America Intravenous Iron Drugs Sales by Type (2017-2022) & (K Units)
• Table 48. North America Intravenous Iron Drugs Sales by Type (2023-2028) & (K Units)
• Table 49. North America Intravenous Iron Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 50. North America Intravenous Iron Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 51. North America Intravenous Iron Drugs Sales by Application (2017-2022) & (K Units)
• Table 52. North America Intravenous Iron Drugs Sales by Application (2023-2028) & (K Units)
• Table 53. North America Intravenous Iron Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 54. North America Intravenous Iron Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 55. North America Intravenous Iron Drugs Sales by Country (2017-2022) & (K Units)
• Table 56. North America Intravenous Iron Drugs Sales by Country (2023-2028) & (K Units)
• Table 57. North America Intravenous Iron Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 58. North America Intravenous Iron Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 59. Europe Intravenous Iron Drugs Sales by Type (2017-2022) & (K Units)
• Table 60. Europe Intravenous Iron Drugs Sales by Type (2023-2028) & (K Units)
• Table 61. Europe Intravenous Iron Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 62. Europe Intravenous Iron Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 63. Europe Intravenous Iron Drugs Sales by Application (2017-2022) & (K Units)
• Table 64. Europe Intravenous Iron Drugs Sales by Application (2023-2028) & (K Units)
• Table 65. Europe Intravenous Iron Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 66. Europe Intravenous Iron Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 67. Europe Intravenous Iron Drugs Sales by Country (2017-2022) & (K Units)
• Table 68. Europe Intravenous Iron Drugs Sales by Country (2023-2028) & (K Units)
• Table 69. Europe Intravenous Iron Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 70. Europe Intravenous Iron Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 71. Asia Pacific Intravenous Iron Drugs Sales by Type (2017-2022) & (K Units)
• Table 72. Asia Pacific Intravenous Iron Drugs Sales by Type (2023-2028) & (K Units)
• Table 73. Asia Pacific Intravenous Iron Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 74. Asia Pacific Intravenous Iron Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 75. Asia Pacific Intravenous Iron Drugs Sales by Application (2017-2022) & (K Units)
• Table 76. Asia Pacific Intravenous Iron Drugs Sales by Application (2023-2028) & (K Units)
• Table 77. Asia Pacific Intravenous Iron Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 78. Asia Pacific Intravenous Iron Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 79. Asia Pacific Intravenous Iron Drugs Sales by Region (2017-2022) & (K Units)
• Table 80. Asia Pacific Intravenous Iron Drugs Sales by Region (2023-2028) & (K Units)
• Table 81. Asia Pacific Intravenous Iron Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 82. Asia Pacific Intravenous Iron Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 83. Latin America Intravenous Iron Drugs Sales by Type (2017-2022) & (K Units)
• Table 84. Latin America Intravenous Iron Drugs Sales by Type (2023-2028) & (K Units)
• Table 85. Latin America Intravenous Iron Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 86. Latin America Intravenous Iron Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 87. Latin America Intravenous Iron Drugs Sales by Application (2017-2022) & (K Units)
• Table 88. Latin America Intravenous Iron Drugs Sales by Application (2023-2028) & (K Units)
• Table 89. Latin America Intravenous Iron Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 90. Latin America Intravenous Iron Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 91. Latin America Intravenous Iron Drugs Sales by Country (2017-2022) & (K Units)
• Table 92. Latin America Intravenous Iron Drugs Sales by Country (2023-2028) & (K Units)
• Table 93. Latin America Intravenous Iron Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 94. Latin America Intravenous Iron Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 95. Middle East and Africa Intravenous Iron Drugs Sales by Type (2017-2022) & (K Units)
• Table 96. Middle East and Africa Intravenous Iron Drugs Sales by Type (2023-2028) & (K Units)
• Table 97. Middle East and Africa Intravenous Iron Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 98. Middle East and Africa Intravenous Iron Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 99. Middle East and Africa Intravenous Iron Drugs Sales by Application (2017-2022) & (K Units)
• Table 100. Middle East and Africa Intravenous Iron Drugs Sales by Application (2023-2028) & (K Units)
• Table 101. Middle East and Africa Intravenous Iron Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 102. Middle East and Africa Intravenous Iron Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 103. Middle East and Africa Intravenous Iron Drugs Sales by Country (2017-2022) & (K Units)
• Table 104. Middle East and Africa Intravenous Iron Drugs Sales by Country (2023-2028) & (K Units)
• Table 105. Middle East and Africa Intravenous Iron Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 106. Middle East and Africa Intravenous Iron Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 107. Allergan Corporation Information
• Table 108. Allergan Description and Major Businesses
• Table 109. Allergan Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 110. Allergan Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Allergan Recent Developments
• Table 112. AMAG Pharmaceuticals Corporation Information
• Table 113. AMAG Pharmaceuticals Description and Major Businesses
• Table 114. AMAG Pharmaceuticals Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 115. AMAG Pharmaceuticals Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. AMAG Pharmaceuticals Recent Developments
• Table 117. Daiichi Sankyo Corporation Information
• Table 118. Daiichi Sankyo Description and Major Businesses
• Table 119. Daiichi Sankyo Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 120. Daiichi Sankyo Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Daiichi Sankyo Recent Developments
• Table 122. Galenica Corporation Information
• Table 123. Galenica Description and Major Businesses
• Table 124. Galenica Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 125. Galenica Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Galenica Recent Developments
• Table 127. Pharmacosmos Corporation Information
• Table 128. Pharmacosmos Description and Major Businesses
• Table 129. Pharmacosmos Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 130. Pharmacosmos Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Pharmacosmos Recent Developments
• Table 132. Nippon Shinyaku Corporation Information
• Table 133. Nippon Shinyaku Description and Major Businesses
• Table 134. Nippon Shinyaku Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 135. Nippon Shinyaku Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Nippon Shinyaku Recent Developments
• Table 137. NOXXON Pharma Corporation Information
• Table 138. NOXXON Pharma Description and Major Businesses
• Table 139. NOXXON Pharma Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 140. NOXXON Pharma Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. NOXXON Pharma Recent Developments
• Table 142. Rockwell Medical Corporation Information
• Table 143. Rockwell Medical Description and Major Businesses
• Table 144. Rockwell Medical Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 145. Rockwell Medical Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Rockwell Medical Recent Developments
• Table 147. Sanofi Corporation Information
• Table 148. Sanofi Description and Major Businesses
• Table 149. Sanofi Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 150. Sanofi Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Sanofi Recent Developments
• Table 152. Wanbang Biopharmaceutical Corporation Information
• Table 153. Wanbang Biopharmaceutical Description and Major Businesses
• Table 154. Wanbang Biopharmaceutical Intravenous Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 155. Wanbang Biopharmaceutical Intravenous Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Wanbang Biopharmaceutical Recent Developments
• Table 157. Key Raw Materials Lists
• Table 158. Raw Materials Key Suppliers Lists
• Table 159. Intravenous Iron Drugs Distributors List
• Table 160. Intravenous Iron Drugs Customers List
• Table 161. Intravenous Iron Drugs Market Trends
• Table 162. Intravenous Iron Drugs Market Drivers
• Table 163. Intravenous Iron Drugs Market Challenges
• Table 164. Intravenous Iron Drugs Market Restraints
• Table 165. Research Programs/Design for This Report
• Table 166. Key Data Information from Secondary Sources
• Table 167. Key Data Information from Primary Sources

List of Figures

• Figure 1. Intravenous Iron Drugs Product Picture
• Figure 3. Global Intravenous Iron Drugs Market Share by Type in 2021 & 2028
• Figure 3. Ferric Gluconate Product Picture
• Figure 4. Ferric Carboxymaltose Product Picture
• Figure 5. Iron Sucrose Product Picture
• Figure 6. Iron Dextran Product Picture
• Figure 7. Global Intravenous Iron Drugs Market Share by Application in 2021 & 2028
• Figure 8. Nephrology
• Figure 9. Gynecology & Obstetrics
• Figure 10. Gastroenterology
• Figure 11. Oncology
• Figure 12. Cardiology
• Figure 13. Others
• Figure 14. Intravenous Iron Drugs Report Years Considered
• Figure 15. Global Intravenous Iron Drugs Sales 2017-2028 (K Units)
• Figure 16. Global Intravenous Iron Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 17. Global Intravenous Iron Drugs Revenue 2017-2028 (US$ Million)
• Figure 18. Global Intravenous Iron Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 19. Global Intravenous Iron Drugs Sales Market Share by Region (2017-2022)
• Figure 20. Global Intravenous Iron Drugs Sales Market Share by Region (2023-2028)
• Figure 21. North America Intravenous Iron Drugs Sales YoY (2017-2028) & (K Units)
• Figure 22. North America Intravenous Iron Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 23. Europe Intravenous Iron Drugs Sales YoY (2017-2028) & (K Units)
• Figure 24. Europe Intravenous Iron Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. Asia-Pacific Intravenous Iron Drugs Sales YoY (2017-2028) & (K Units)
• Figure 26. Asia-Pacific Intravenous Iron Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. Latin America Intravenous Iron Drugs Sales YoY (2017-2028) & (K Units)
• Figure 28. Latin America Intravenous Iron Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 29. Middle East & Africa Intravenous Iron Drugs Sales YoY (2017-2028) & (K Units)
• Figure 30. Middle East & Africa Intravenous Iron Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 31. The Intravenous Iron Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 32. The Top 5 and 10 Largest Manufacturers of Intravenous Iron Drugs in the World: Market Share by Intravenous Iron Drugs Revenue in 2021
• Figure 33. Global Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 34. Global Intravenous Iron Drugs Sales Market Share by Type (2017-2028)
• Figure 35. Global Intravenous Iron Drugs Revenue Market Share by Type (2017-2028)
• Figure 36. Global Intravenous Iron Drugs Sales Market Share by Application (2017-2028)
• Figure 37. Global Intravenous Iron Drugs Revenue Market Share by Application (2017-2028)
• Figure 38. North America Intravenous Iron Drugs Sales Market Share by Type (2017-2028)
• Figure 39. North America Intravenous Iron Drugs Revenue Market Share by Type (2017-2028)
• Figure 40. North America Intravenous Iron Drugs Sales Market Share by Application (2017-2028)
• Figure 41. North America Intravenous Iron Drugs Revenue Market Share by Application (2017-2028)
• Figure 42. North America Intravenous Iron Drugs Sales Share by Country (2017-2028)
• Figure 43. North America Intravenous Iron Drugs Revenue Share by Country (2017-2028)
• Figure 44. U.S. Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 45. Canada Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 46. Europe Intravenous Iron Drugs Sales Market Share by Type (2017-2028)
• Figure 47. Europe Intravenous Iron Drugs Revenue Market Share by Type (2017-2028)
• Figure 48. Europe Intravenous Iron Drugs Sales Market Share by Application (2017-2028)
• Figure 49. Europe Intravenous Iron Drugs Revenue Market Share by Application (2017-2028)
• Figure 50. Europe Intravenous Iron Drugs Sales Share by Country (2017-2028)
• Figure 51. Europe Intravenous Iron Drugs Revenue Share by Country (2017-2028)
• Figure 52. Germany Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 53. France Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 54. U.K. Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 55. Italy Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 56. Russia Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 57. Asia Pacific Intravenous Iron Drugs Sales Market Share by Type (2017-2028)
• Figure 58. Asia Pacific Intravenous Iron Drugs Revenue Market Share by Type (2017-2028)
• Figure 59. Asia Pacific Intravenous Iron Drugs Sales Market Share by Application (2017-2028)
• Figure 60. Asia Pacific Intravenous Iron Drugs Revenue Market Share by Application (2017-2028)
• Figure 61. Asia Pacific Intravenous Iron Drugs Sales Share by Region (2017-2028)
• Figure 62. Asia Pacific Intravenous Iron Drugs Revenue Share by Region (2017-2028)
• Figure 63. China Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 64. Japan Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 65. South Korea Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 66. India Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 67. Australia Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 68. Taiwan Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 69. Indonesia Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 70. Thailand Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 71. Malaysia Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 72. Philippines Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 73. Latin America Intravenous Iron Drugs Sales Market Share by Type (2017-2028)
• Figure 74. Latin America Intravenous Iron Drugs Revenue Market Share by Type (2017-2028)
• Figure 75. Latin America Intravenous Iron Drugs Sales Market Share by Application (2017-2028)
• Figure 76. Latin America Intravenous Iron Drugs Revenue Market Share by Application (2017-2028)
• Figure 77. Latin America Intravenous Iron Drugs Sales Share by Country (2017-2028)
• Figure 78. Latin America Intravenous Iron Drugs Revenue Share by Country (2017-2028)
• Figure 79. Mexico Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 80. Brazil Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 81. Argentina Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 82. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Type (2017-2028)
• Figure 83. Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Type (2017-2028)
• Figure 84. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Application (2017-2028)
• Figure 85. Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Application (2017-2028)
• Figure 86. Middle East and Africa Intravenous Iron Drugs Sales Share by Country (2017-2028)
• Figure 87. Middle East and Africa Intravenous Iron Drugs Revenue Share by Country (2017-2028)
• Figure 88. Turkey Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 89. Saudi Arabia Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 90. U.A.E Intravenous Iron Drugs Revenue (2017-2028) & (US$ Million)
• Figure 91. Intravenous Iron Drugs Value Chain
• Figure 92. Intravenous Iron Drugs Production Process
• Figure 93. Channels of Distribution
• Figure 94. Distributors Profiles
• Figure 95. Bottom-up and Top-down Approaches for This Report
• Figure 96. Data Triangulation
• Figure 97. Key Executives Interviewed